@hemehub.bsky.social
HemeHub (formerly BMFCases) | Supporting hematology by enhancing care, driving innovation, and advancing research & treatment strategies.
https://www.hemehub.org
https://www.hemehub.org
A vibrant evening at #ASH with colleagues, culture, and new insights shaping hematology. Get ready for HemeHub’s Post-ASH 2025 Updates featuring Dr. Ibrahim and Dr. Bat this Friday, December 12th at 7:30 AM CT.
#ASH2025 #Hematology #ClinicalInsights #HEMEHUB
#ASH2025 #Hematology #ClinicalInsights #HEMEHUB
December 9, 2025 at 12:23 AM
A vibrant evening at #ASH with colleagues, culture, and new insights shaping hematology. Get ready for HemeHub’s Post-ASH 2025 Updates featuring Dr. Ibrahim and Dr. Bat this Friday, December 12th at 7:30 AM CT.
#ASH2025 #Hematology #ClinicalInsights #HEMEHUB
#ASH2025 #Hematology #ClinicalInsights #HEMEHUB
#HemeHub is proud to share that Omisirge (omidubicel), featured in our session with Dr. Richard Childs, is now #FDA approved for severe aplastic anemia, bringing hope to patients without a matched donor.
Watch the moment from our HemeHub session: youtu.be/w9SHBLQDmd4?...
Read the FDA update today!
Watch the moment from our HemeHub session: youtu.be/w9SHBLQDmd4?...
Read the FDA update today!
December 9, 2025 at 12:17 AM
#HemeHub is proud to share that Omisirge (omidubicel), featured in our session with Dr. Richard Childs, is now #FDA approved for severe aplastic anemia, bringing hope to patients without a matched donor.
Watch the moment from our HemeHub session: youtu.be/w9SHBLQDmd4?...
Read the FDA update today!
Watch the moment from our HemeHub session: youtu.be/w9SHBLQDmd4?...
Read the FDA update today!
HemeHub is at #ASH2025, fighting for progress in hematology through collaboration and education. Join us for our Post ASH Updates 2025 this Friday, December 12th at 7:30 AM CT.
Register: hemehub.org/live-events
#ASH25 #HemeHub #HematologyUpdates #Hematology
Register: hemehub.org/live-events
#ASH25 #HemeHub #HematologyUpdates #Hematology
December 7, 2025 at 5:57 PM
HemeHub is at #ASH2025, fighting for progress in hematology through collaboration and education. Join us for our Post ASH Updates 2025 this Friday, December 12th at 7:30 AM CT.
Register: hemehub.org/live-events
#ASH25 #HemeHub #HematologyUpdates #Hematology
Register: hemehub.org/live-events
#ASH25 #HemeHub #HematologyUpdates #Hematology
🩸 Stay informed with HemeHub’s independent, timely updates that support patient-centered care.
➡️ Data-driven updates
➡️ Critically appraised insights to guide clinical judgment
➡️ Resources that promote high-value, thoughtful care
🌐 Learn more at hemehub.org
#HemeHub #Hematology #HemeCommunity
➡️ Data-driven updates
➡️ Critically appraised insights to guide clinical judgment
➡️ Resources that promote high-value, thoughtful care
🌐 Learn more at hemehub.org
#HemeHub #Hematology #HemeCommunity
December 7, 2025 at 1:31 AM
🩸 Stay informed with HemeHub’s independent, timely updates that support patient-centered care.
➡️ Data-driven updates
➡️ Critically appraised insights to guide clinical judgment
➡️ Resources that promote high-value, thoughtful care
🌐 Learn more at hemehub.org
#HemeHub #Hematology #HemeCommunity
➡️ Data-driven updates
➡️ Critically appraised insights to guide clinical judgment
➡️ Resources that promote high-value, thoughtful care
🌐 Learn more at hemehub.org
#HemeHub #Hematology #HemeCommunity
Share your challenging cases and contribute to discussion with leading experts. De-identified cases presented during live sessions offer an opportunity for diverse #clinical perspectives.
🌐You can submit your own cases for the upcoming sessions at hemehub.org/case-submiss...
#Heme #MedEd #HemeHub
🌐You can submit your own cases for the upcoming sessions at hemehub.org/case-submiss...
#Heme #MedEd #HemeHub
December 4, 2025 at 10:19 PM
Share your challenging cases and contribute to discussion with leading experts. De-identified cases presented during live sessions offer an opportunity for diverse #clinical perspectives.
🌐You can submit your own cases for the upcoming sessions at hemehub.org/case-submiss...
#Heme #MedEd #HemeHub
🌐You can submit your own cases for the upcoming sessions at hemehub.org/case-submiss...
#Heme #MedEd #HemeHub
Our expert-led session on #HemophiliaA featuring Dr. Shannon Meeks, MD is available to watch anytime!
➡️ Full session: youtu.be/eXyf0Tykg3w?...
🌐 You can also access previous sessions directly at hemehub.org and on YouTube!
@htrstoday.bsky.social @athnnews.bsky.social @sfthemostase.bsky.social
➡️ Full session: youtu.be/eXyf0Tykg3w?...
🌐 You can also access previous sessions directly at hemehub.org and on YouTube!
@htrstoday.bsky.social @athnnews.bsky.social @sfthemostase.bsky.social
December 4, 2025 at 9:49 PM
Our expert-led session on #HemophiliaA featuring Dr. Shannon Meeks, MD is available to watch anytime!
➡️ Full session: youtu.be/eXyf0Tykg3w?...
🌐 You can also access previous sessions directly at hemehub.org and on YouTube!
@htrstoday.bsky.social @athnnews.bsky.social @sfthemostase.bsky.social
➡️ Full session: youtu.be/eXyf0Tykg3w?...
🌐 You can also access previous sessions directly at hemehub.org and on YouTube!
@htrstoday.bsky.social @athnnews.bsky.social @sfthemostase.bsky.social
🩸Join us for post #ASH2025 updates as leading experts break down the most impactful clinical and scientific findings from the 67th ASH Annual Meeting.
Register now: hemehub.org/live-events
Submit your own cases: hemehub.org/case-submiss...
#ASH25 #Hematology #ClinicalInsights #HEMEHUB
Register now: hemehub.org/live-events
Submit your own cases: hemehub.org/case-submiss...
#ASH25 #Hematology #ClinicalInsights #HEMEHUB
December 3, 2025 at 9:12 PM
🩸Join us for post #ASH2025 updates as leading experts break down the most impactful clinical and scientific findings from the 67th ASH Annual Meeting.
Register now: hemehub.org/live-events
Submit your own cases: hemehub.org/case-submiss...
#ASH25 #Hematology #ClinicalInsights #HEMEHUB
Register now: hemehub.org/live-events
Submit your own cases: hemehub.org/case-submiss...
#ASH25 #Hematology #ClinicalInsights #HEMEHUB
Catch up on HemeHub webinars anytime!
Watch webinars and past sessions anytime on our website — all organized by topic for easy navigation.
🔗Visit hemehub.org today!
#HemeHub #Hematology #HemeEd #MedEd #MedicalEducation #OnlineLearning #HemeCommunity
Watch webinars and past sessions anytime on our website — all organized by topic for easy navigation.
🔗Visit hemehub.org today!
#HemeHub #Hematology #HemeEd #MedEd #MedicalEducation #OnlineLearning #HemeCommunity
December 1, 2025 at 11:46 PM
Catch up on HemeHub webinars anytime!
Watch webinars and past sessions anytime on our website — all organized by topic for easy navigation.
🔗Visit hemehub.org today!
#HemeHub #Hematology #HemeEd #MedEd #MedicalEducation #OnlineLearning #HemeCommunity
Watch webinars and past sessions anytime on our website — all organized by topic for easy navigation.
🔗Visit hemehub.org today!
#HemeHub #Hematology #HemeEd #MedEd #MedicalEducation #OnlineLearning #HemeCommunity
Missed our session with Dr. Thomas Coates on Sickle Cell Disease and Gene Therapy?
The full recording is now available on our YouTube channel!
➡️Watch the full session: youtu.be/TDNCgKR3p18?...
#GeneTherapy #SickleCellGeneTherapy #SickleCellDisease #Hematology #CellTherapy #RareDiseases
The full recording is now available on our YouTube channel!
➡️Watch the full session: youtu.be/TDNCgKR3p18?...
#GeneTherapy #SickleCellGeneTherapy #SickleCellDisease #Hematology #CellTherapy #RareDiseases
December 1, 2025 at 2:19 AM
Missed our session with Dr. Thomas Coates on Sickle Cell Disease and Gene Therapy?
The full recording is now available on our YouTube channel!
➡️Watch the full session: youtu.be/TDNCgKR3p18?...
#GeneTherapy #SickleCellGeneTherapy #SickleCellDisease #Hematology #CellTherapy #RareDiseases
The full recording is now available on our YouTube channel!
➡️Watch the full session: youtu.be/TDNCgKR3p18?...
#GeneTherapy #SickleCellGeneTherapy #SickleCellDisease #Hematology #CellTherapy #RareDiseases
Today's second question focuses on the genetic mechanism leading to low factor VIII levels and bleeding in female carriers of Hemophilia A.
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #ClinicalTrials
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #ClinicalTrials
November 29, 2025 at 12:38 AM
Today's second question focuses on the genetic mechanism leading to low factor VIII levels and bleeding in female carriers of Hemophilia A.
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #ClinicalTrials
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #ClinicalTrials
Today’s first question focuses on the genetic mechanism underlying unexpected severe bleeding in an infant with no maternal bleeding history.
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #ClinicalTrials
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #ClinicalTrials
November 29, 2025 at 12:37 AM
Today’s first question focuses on the genetic mechanism underlying unexpected severe bleeding in an infant with no maternal bleeding history.
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #ClinicalTrials
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #ClinicalTrials
Facts about Hemophilia A: Inhibitors and Immune Complications, and Future Directions
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #InternalMedicine #ClinicalTrials #BloodDisorders @htrstoday.bsky.social @thjournal.bsky.social @sfthemostase.bsky.social
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #InternalMedicine #ClinicalTrials #BloodDisorders @htrstoday.bsky.social @thjournal.bsky.social @sfthemostase.bsky.social
November 29, 2025 at 12:37 AM
Facts about Hemophilia A: Inhibitors and Immune Complications, and Future Directions
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #InternalMedicine #ClinicalTrials #BloodDisorders @htrstoday.bsky.social @thjournal.bsky.social @sfthemostase.bsky.social
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #InternalMedicine #ClinicalTrials #BloodDisorders @htrstoday.bsky.social @thjournal.bsky.social @sfthemostase.bsky.social
The second question of the day!
See the answer and explanation on the next slide.
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab #InternalMedicine #ClinicalTrials #BloodDisorders @htrstoday.bsky.social @thjournal.bsky.social @ash.edu.hematology.org
See the answer and explanation on the next slide.
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab #InternalMedicine #ClinicalTrials #BloodDisorders @htrstoday.bsky.social @thjournal.bsky.social @ash.edu.hematology.org
November 27, 2025 at 3:41 AM
The second question of the day!
See the answer and explanation on the next slide.
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab #InternalMedicine #ClinicalTrials #BloodDisorders @htrstoday.bsky.social @thjournal.bsky.social @ash.edu.hematology.org
See the answer and explanation on the next slide.
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab #InternalMedicine #ClinicalTrials #BloodDisorders @htrstoday.bsky.social @thjournal.bsky.social @ash.edu.hematology.org
Today's first question!
See the answer and explanation on the next slide.
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab #ClinicalTrials #BloodDisorders @htrstoday.bsky.social @thjournal.bsky.social @sfthemostase.bsky.social @ash.edu.hematology.org
See the answer and explanation on the next slide.
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab #ClinicalTrials #BloodDisorders @htrstoday.bsky.social @thjournal.bsky.social @sfthemostase.bsky.social @ash.edu.hematology.org
November 27, 2025 at 3:40 AM
Today's first question!
See the answer and explanation on the next slide.
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab #ClinicalTrials #BloodDisorders @htrstoday.bsky.social @thjournal.bsky.social @sfthemostase.bsky.social @ash.edu.hematology.org
See the answer and explanation on the next slide.
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab #ClinicalTrials #BloodDisorders @htrstoday.bsky.social @thjournal.bsky.social @sfthemostase.bsky.social @ash.edu.hematology.org
Facts about Hemophilia A: Rebalancing and RNA-Based Therapies
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab #ClinicalTrials #BloodDisorders @htrstoday.bsky.social @thjournal.bsky.social @sfthemostase.bsky.social @ash.edu.hematology.org
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab #ClinicalTrials #BloodDisorders @htrstoday.bsky.social @thjournal.bsky.social @sfthemostase.bsky.social @ash.edu.hematology.org
November 27, 2025 at 3:39 AM
Facts about Hemophilia A: Rebalancing and RNA-Based Therapies
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab #ClinicalTrials #BloodDisorders @htrstoday.bsky.social @thjournal.bsky.social @sfthemostase.bsky.social @ash.edu.hematology.org
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab #ClinicalTrials #BloodDisorders @htrstoday.bsky.social @thjournal.bsky.social @sfthemostase.bsky.social @ash.edu.hematology.org
The second question of the day focuses on understanding complications in patients receiving fitusiran prophylaxis.
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab #InternalMedicine #ClinicalTrials
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab #InternalMedicine #ClinicalTrials
November 25, 2025 at 3:09 AM
The second question of the day focuses on understanding complications in patients receiving fitusiran prophylaxis.
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab #InternalMedicine #ClinicalTrials
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab #InternalMedicine #ClinicalTrials
Today’s first question focuses on why a child on regular recombinant Factor VIII prophylaxis may still experience several bleeding episodes each year.
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab
November 25, 2025 at 3:09 AM
Today’s first question focuses on why a child on regular recombinant Factor VIII prophylaxis may still experience several bleeding episodes each year.
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab
Facts about Hemophilia A: Non-Factor (Substitution) Therapies
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab #ClinicalTrials #BloodDisorders @htrstoday.bsky.social @thjournal.bsky.social @sfthemostase.bsky.social @ash.edu.hematology.org
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab #ClinicalTrials #BloodDisorders @htrstoday.bsky.social @thjournal.bsky.social @sfthemostase.bsky.social @ash.edu.hematology.org
November 25, 2025 at 3:08 AM
Facts about Hemophilia A: Non-Factor (Substitution) Therapies
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab #ClinicalTrials #BloodDisorders @htrstoday.bsky.social @thjournal.bsky.social @sfthemostase.bsky.social @ash.edu.hematology.org
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab #ClinicalTrials #BloodDisorders @htrstoday.bsky.social @thjournal.bsky.social @sfthemostase.bsky.social @ash.edu.hematology.org
Today’s question focuses on the type of viral vector most commonly used in gene therapy trials for Hemophilia A.
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab #InternalMedicine #ClinicalTrials
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab #InternalMedicine #ClinicalTrials
November 21, 2025 at 10:28 PM
Today’s question focuses on the type of viral vector most commonly used in gene therapy trials for Hemophilia A.
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab #InternalMedicine #ClinicalTrials
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab #InternalMedicine #ClinicalTrials
Facts about Hemophilia A: Treatment — Factor Replacement Era
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #GeneTherapy #Emicizumab #InternalMedicine #ClinicalTrials #BloodDisorders @thjournal.bsky.social @htrstoday.bsky.social @sfthemostase.bsky.social @ash.edu.hematology.org
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #GeneTherapy #Emicizumab #InternalMedicine #ClinicalTrials #BloodDisorders @thjournal.bsky.social @htrstoday.bsky.social @sfthemostase.bsky.social @ash.edu.hematology.org
November 21, 2025 at 10:28 PM
Facts about Hemophilia A: Treatment — Factor Replacement Era
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #GeneTherapy #Emicizumab #InternalMedicine #ClinicalTrials #BloodDisorders @thjournal.bsky.social @htrstoday.bsky.social @sfthemostase.bsky.social @ash.edu.hematology.org
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #GeneTherapy #Emicizumab #InternalMedicine #ClinicalTrials #BloodDisorders @thjournal.bsky.social @htrstoday.bsky.social @sfthemostase.bsky.social @ash.edu.hematology.org
Today’s question focuses on safe management of breakthrough bleeding in a patient receiving emicizumab prophylaxis.
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab #InternalMedicine #ClinicalTrials
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab #InternalMedicine #ClinicalTrials
November 20, 2025 at 8:37 PM
Today’s question focuses on safe management of breakthrough bleeding in a patient receiving emicizumab prophylaxis.
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab #InternalMedicine #ClinicalTrials
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab #InternalMedicine #ClinicalTrials
Facts about Hemophilia A:
Additional information on diagnosis and screening
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab #InternalMedicine #ClinicalTrials #BloodDisorders @htrstoday.bsky.social @sfthemostase.bsky.social @thjournal.bsky.social
Additional information on diagnosis and screening
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab #InternalMedicine #ClinicalTrials #BloodDisorders @htrstoday.bsky.social @sfthemostase.bsky.social @thjournal.bsky.social
November 20, 2025 at 8:36 PM
Facts about Hemophilia A:
Additional information on diagnosis and screening
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab #InternalMedicine #ClinicalTrials #BloodDisorders @htrstoday.bsky.social @sfthemostase.bsky.social @thjournal.bsky.social
Additional information on diagnosis and screening
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab #InternalMedicine #ClinicalTrials #BloodDisorders @htrstoday.bsky.social @sfthemostase.bsky.social @thjournal.bsky.social
Today’s question focuses on the expected laboratory pattern in a child with Hemophilia A who presents with bleeding after missing a prophylactic infusion.
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy
November 17, 2025 at 11:13 PM
Today’s question focuses on the expected laboratory pattern in a child with Hemophilia A who presents with bleeding after missing a prophylactic infusion.
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy
Facts about Hemophilia A: Diagnosis and Screening
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab #InternalMedicine #ClinicalTrials #BloodDisorders @thjournal.bsky.social @htrstoday.bsky.social @sfthemostase.bsky.social @ash.edu.hematology.org
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab #InternalMedicine #ClinicalTrials #BloodDisorders @thjournal.bsky.social @htrstoday.bsky.social @sfthemostase.bsky.social @ash.edu.hematology.org
November 17, 2025 at 11:10 PM
Facts about Hemophilia A: Diagnosis and Screening
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab #InternalMedicine #ClinicalTrials #BloodDisorders @thjournal.bsky.social @htrstoday.bsky.social @sfthemostase.bsky.social @ash.edu.hematology.org
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab #InternalMedicine #ClinicalTrials #BloodDisorders @thjournal.bsky.social @htrstoday.bsky.social @sfthemostase.bsky.social @ash.edu.hematology.org
Today’s question focuses on hemostatic management before a dental procedure in a patient with mild Hemophilia A.
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy
November 16, 2025 at 12:25 AM
Today’s question focuses on hemostatic management before a dental procedure in a patient with mild Hemophilia A.
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy